Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue
| Status: | Recruiting |
|---|---|
| Conditions: | Cancer, Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 5/26/2018 |
| Start Date: | January 2, 2018 |
| End Date: | June 2020 |
| Contact: | Stephanie M Munz, DDS |
| Email: | smmunz@med.umich.edu |
| Phone: | 734 936-8289 |
Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue (PGSRT): a Randomized Clinical Trial
This study will fill a scientific gap in the current knowledge providing data for evaluation
of the palatal augmentation prosthesis as a therapeutic modality in a robust scientific
randomized prospective clinical trial. Positive outcomes from this study have the potential
to dramatically alter the most common morbidity of oral cancer therapy, namely speech and
swallowing function in a population of patients with T1/T2 tumors of the tongue who are not
currently routinely recommended for a palatal augmentation prosthesis.
of the palatal augmentation prosthesis as a therapeutic modality in a robust scientific
randomized prospective clinical trial. Positive outcomes from this study have the potential
to dramatically alter the most common morbidity of oral cancer therapy, namely speech and
swallowing function in a population of patients with T1/T2 tumors of the tongue who are not
currently routinely recommended for a palatal augmentation prosthesis.
Inclusion Criteria:
- Patients with a new diagnosis of a T1/T2 tongue cancer
Exclusion Criteria:
- Patients with recurrent disease
- Patients with a history of prior head and neck radiation therapy
- Patients who lack adequate maxillary dentition to support a palatal augmentation
prosthesis
We found this trial at
1
site
Ann Arbor, Michigan 48109
Phone: 734-936-8289
Click here to add this to my saved trials
